Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram Augmentation in Treatment Resistant Schizophrenia
NCT00231335Phase 4Completed
- Sponsor
- Emory University
- Start
- Mar 2006
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of escitalopram in schizophrenia, schizoaffective disorder, sponsored by Emory University. Started Mar 2006; status: completed.
02
Drugs
escitalopram
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00231335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231335.